We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,264

Florida’s New Medical Marijuana Law and Telemedicine Exams
  • Foley & Lardner LLP
  • USA
  • June 14 2017

Following a special session, the Florida Legislature on June 9, 2017 passed two important bills regarding medical marijuana in the Sunshine State: SB


Industry Perspectives On The Biosimilar Patent Dance
  • Foley & Lardner LLP
  • USA
  • June 12 2017

The Supreme Court could issue its decision in the Amgen v. Sandoz biosimilar patent dance case any day now. Last week I participated in a panel


Supreme Court Decision Largely Favors Biosimilar Applicants
  • Foley & Lardner LLP
  • USA
  • June 12 2017

The U.S. Supreme Court rendered its first interpretations of the biosimilar patent dispute resolution procedures of the Biologics Price Competition


NIH Begins Beta Test of Million Patient Cohort
  • Foley & Lardner LLP
  • USA
  • June 10 2017

The National Institutes of Health announced the enrollment of the first participants as beta testers of the “All of Us” research program. Initially


SEC and U.S. Attorney’s Office Continue Their Pursuit of Criminal Actions Against Purveyors of “Political Intelligence”
  • Foley & Lardner LLP
  • USA
  • June 9 2017

On May 24, 2017, the United States Attorney’s Office for the Southern District of New York and the Securities and Exchange Commission (SEC) launched


Senate Sets Timeline to Take up Repeal and Replace Legislation on ACA
  • Foley & Lardner LLP
  • USA
  • June 7 2017

With Congress returning to Washington, D.C. from its Memorial Day work period, Senators are focusing heavily on the timeline and details of


Court Questions Applicability of Function Way Result Test In Chemical Cases
  • Foley & Lardner LLP
  • USA
  • May 31 2017

In Mylan Institutional LLC v. Aurobindo Pharma Ltd., the Federal Circuit reviewed a preliminary injunction based in part on a finding of likelihood


New FDA Commissioner Hits the Ground Running
  • Foley & Lardner LLP
  • USA
  • May 30 2017

Fresh off his noticeably smooth confirmation, the new Commissioner of Food and Drugs, Dr. Scott Gottlieb, appeared before Congress last Thursday and


Florida Board of Medicine to Hold Another Hearing on Telemedicine and Medical Marijuana Rules
  • Foley & Lardner LLP
  • USA
  • May 24 2017

On August 4, 2017, the Florida Board of Medicine will hold a third public hearing to discuss its proposed amendment to Florida’s telemedicine


CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language
  • Foley & Lardner LLP
  • USA
  • May 23 2017

In a non-precedential decision issued in Braintree Labs., Inc. v. Breckenridge Pharmaceutical, Inc., the Federal Circuit reversed the district